Director, BD&L Forecasting
CSL
About this role
The role leads BD&L forecasting and portfolio analytics for Cardiovascular & Renal and Transplant & Immunology therapy areas, representing the Insights & Analytics forecasting function within commercial due diligence. It is responsible for shaping strategic direction and optimizing the pharmaceutical portfolio through data-driven revenue forecasting and analytics. The position is part of the Global I&A team at CSL Behring and partners across functions to inform business development and investment decisions.
Skills
Qualifications
About CSL
csl.comCSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
Recent company news
About CSL
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for CSL.
Salary
$121k – $163k
per year